Clinical trial NCT01347229: SENSIMED Triggerfish® in Sitting and Supine Position
Official title: Assessment of Sitting and Supine Position IOP Using SENSIMED Triggerfish® and Standard Tonometers
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Healthy Subjects
Keywords: Glaucoma
Triggerfish
body position
Lead sponsor: Sensimed AG
Sponsor class: INDUSTRY
First posted: 2011-05-04
Enrollment: 20
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: The purpose of the study is to evaluate changes in intraocular pressure (IOP) between sitting and supine body positions and correlate the values obtained with conventional tonometers to the output provided by the investigational device.

Detailed description: 20 subjects will be enrolled in the investigation. Eligible subjects will receive one session of 22-hour continuous IOP monitoring with SENSIMED Triggerfish® in ambulatory mode, with body position transitions carried out in-hospital. SENSIMED Triggerfish® will be installed randomly on right or left eyes and the IOP recording will be initiated as soon as the adaptation of the device on the subject's eye is satisfying. Subjects will then go home. The next morning, subjects will return to the hospital and during SENSIMED Triggerfish® monitoring on one eye, IOP measurements will be taken in the fellow eye in sitting position using Goldmann, tonopen and pneuma-tonometers. Then subjects will lie down on a flat bed. After 15 ± 5 minutes and again after 45 ± 5 minutes IOP will be measured in supine position, using Goldmann, tonopen, pneuma-tonometer and Perkins tonometers. Then subjects will sit up again. After 30 ± 5 minutes IOP will be measured with the Goldmann tonometer.

Eligibility criteria: Inclusion Criteria:

* Subject is able to provide informed consent
* Healthy subject, with no previous ocular medical history, with the exception of spectacle vision correction for myopia, hyperopia and astigmatism
* No more than 4 diopters spherical equivalent
* No more than 2 diopters cylinder equivalent
* GAT IOP of less than or equal to 21 mmHg at inclusion and open iridocorneal angles, no history of any IOP \> 21 mmHg
* GAT IOP difference between eyes within 1 mmHg during initial exam
* GAT IOP differences between initial sitting and supine positions, between left and right eyes, within 2 mmHg during initial exam
* ≥ 18 years
* For women with childbearing potential, adequate contraception

Exclusion Criteria:

* Subjects with contraindications for wearing contact lenses
* Severe dry eye syndrome
* Keratoconus or other corneal abnormality
* Conjunctival or intraocular inflammation
* History of eye surgery
* Full frame metal glasses during SENSIMED Triggerfish® recording
* Known hypersensitivity to silicone, plaster or ocular anesthesia
* Pregnancy and lactation
* Simultaneous participation in other clinical studies

Primary outcomes:
measure: Difference in study device signal and GAT IOP between the sitting and supine positions during the sitting-supine sequence
timeFrame: 45 minutes
Secondary outcomes:
measure: Difference in Triggerfish® signal and GAT IOP between the sitting and supine positions upon returning to sitting position from supine
timeFrame: 30 minutes
measure: IOP measurements with tonopen and pneuma-tonometer in sitting position, and tonopen, pneuma-tonometer and Perkins in supine position
timeFrame: 2 hours
measure: Monitoring with study device obtained before Day 2
timeFrame: 20 hours
Other outcomes:
Locations:
city: Zerifin
country: Israel
facility: Assaf Harofeh Medical Center
Study officials:
affiliation: Assaf-Harofeh Medical Center
name: Yaniv Barkana, MD
role: PRINCIPAL_INVESTIGATOR
References: